The Minister of Health at the conclusion of the second forum for the manufacture of vaccine and medical preparations in Africa
Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, said that Egypt has paid attention to the file of localizing the industry and medical supplies, on top of which is the vaccines, by taking advantage of successful global experiences and experiences, which qualifies the Egyptian state, to achieve self -sufficiency, targeting the strengthening of local production of vaccine And reducing dependence on imports, which contributes to improving the country’s health and economic situation, as well as opening export doors to sister African countries, to enhance Egypt’s position in the region and internationally.
this came during his speech in the closing session & nbsp; For the second forum for the manufacture of vaccine and medical preparations in Africa in cooperation with the African Center for Disease Control and Prevention (Africa CDC), the Unified Purchase Authority, the Global Opposition Alliance (GAVI), and the regional cooperation project for vaccine manufacturing.
pointed out the Deputy Prime Minister, indicated Egypt is of great importance in the pharmaceutical industry, and has great & nbsp; & nbsp; In addition to the export capabilities in this good sector, due to its structures and companies such as the Egyptian city of medicine & quot; Gibto Pharma & quot; And the company & nbsp; & nbsp; Holding Company for Biomedics and Vaccines & quot; Fixra & quot;, & nbsp; Stressing that the presence of these delegations from international organizations, agencies and international companies & nbsp; An international testimony to Egypt’s success in developing the health system, especially in the field of localizing the pharmaceutical and vaccine industry. Building a large African market according to a future strategic vision that provides the needs of the African citizen from all preparations, supplies and vaccines with high quality, effectiveness and safe Vaccines and other priority medical products in Africa, monitor progress and explore the auxiliary factors for the manufacture of African vaccines with the participation of updates of actors in manufacturing & nbsp; Through visions and strategies, as well as & nbsp; Discussing the plans and capabilities of vaccine production on the continent, in addition to the gaps and challenges in meeting the aspirations of the African Union to produce locally, and review the strategic vision and the work plan to support the manufacture of the main diagnostic and therapeutic products on the continent. That & nbsp; The various forum sessions touched on exploring the pivotal role of vaccine manufacturing alliance in Egypt (EVMA) in facilitating technology transfer and enhancing partnerships, highlighting Egypt’s capabilities as a pioneering center for vaccine manufacturing in Africa, where it has more than 20 % of vaccine manufacturing facilities in the continent, and infrastructure development , And facilitating investment opportunities to enhance local production capabilities. Egypt and the surrounding area, and how to publish innovative partnerships such as EVMA regionally, and review & nbsp; Investment opportunities available to each of the local and international manufacturers that look forward to creating or expanding their operations in Egypt. Inspirational & nbsp; A basic stone for the global alliance for vaccine manufacturing and securing its arrival to the African continent, stressing that the Global Alliance for Vaccines (Gavi) and the African Center (Africa CDC) are actively participating with the stakeholders to form AVMA and there will be continuous cooperation with manufacturers to ensure success and influence, indicating that cooperation exists between The World Health Organization and the African Union (Nepad Amrh) and national organizational bodies to enhance the expansion of mutual accreditation.
